[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1073/pnas.91.7.2752; PubMed=8146186 [NCBI, ExPASy, EBI, Israel, Japan]
Charo I.F.,
Myers S.J.,
Herman A.,
Franci C.,
Connolly A.J.,
Coughlin S.R.;
"Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.";
Proc. Natl. Acad. Sci. U.S.A. 91:2752-2756(1994).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1006/bbrc.1994.2049; PubMed=8048929 [NCBI, ExPASy, EBI, Israel, Japan]
Yamagami S.,
Tokuda Y.,
Ishii K.,
Tamaka H.,
Endo N.;
"cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor.";
Biochem. Biophys. Res. Commun. 202:1156-1162(1994).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
DOI=10.1074/jbc.272.2.1038; PubMed=8995400 [NCBI, ExPASy, EBI, Israel, Japan]
Wong L.-M.,
Myers S.J.,
Tsou C.-L.,
Gosling J.,
Arai H.,
Charo I.F.;
"Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking.";
J. Biol. Chem. 272:1038-1045(1997).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-64 AND GLU-355.
SeattleSNPs variation discovery resource;
Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04728; PubMed=16641997 [NCBI, ExPASy, EBI, Israel, Japan]
Muzny D.M.,
Scherer S.E.,
Kaul R.,
Wang J.,
Yu J.,
Sudbrak R.,
Buhay C.J.,
Chen R.,
Cree A.,
Ding Y.,
Dugan-Rocha S.,
Gill R.,
Gunaratne P.,
Harris R.A.,
Hawes A.C.,
Hernandez J.,
Hodgson A.V.,
Hume J.,
Jackson A.,
Khan Z.M.,
Kovar-Smith C.,
Lewis L.R.,
Lozado R.J.,
Metzker M.L.,
Milosavljevic A.,
Miner G.R.,
Morgan M.B.,
Nazareth L.V.,
Scott G.,
Sodergren E.,
Song X.-Z.,
Steffen D.,
Wei S.,
Wheeler D.A.,
Wright M.W.,
Worley K.C.,
Yuan Y.,
Zhang Z.,
Adams C.Q.,
Ansari-Lari M.A.,
Ayele M.,
Brown M.J.,
Chen G.,
Chen Z.,
Clendenning J.,
Clerc-Blankenburg K.P.,
Chen R.,
Chen Z.,
Davis C.,
Delgado O.,
Dinh H.H.,
Dong W.,
Draper H.,
Ernst S.,
Fu G.,
Gonzalez-Garay M.L.,
Garcia D.K.,
Gillett W.,
Gu J.,
Hao B.,
Haugen E.,
Havlak P.,
He X.,
Hennig S.,
Hu S.,
Huang W.,
Jackson L.R.,
Jacob L.S.,
Kelly S.H.,
Kube M.,
Levy R.,
Li Z.,
Liu B.,
Liu J.,
Liu W.,
Lu J.,
Maheshwari M.,
Nguyen B.-V.,
Okwuonu G.O.,
Palmeiri A.,
Pasternak S.,
Perez L.M.,
Phelps K.A.,
Plopper F.J.,
Qiang B.,
Raymond C.,
Rodriguez R.,
Saenphimmachak C.,
Santibanez J.,
Shen H.,
Shen Y.,
Subramanian S.,
Tabor P.E.,
Verduzco D.,
Waldron L.,
Wang J.,
Wang J.,
Wang Q.,
Williams G.A.,
Wong G.K.-S.,
Yao Z.,
Zhang J.,
Zhang X.,
Zhao G.,
Zhou J.,
Zhou Y.,
Nelson D.,
Lehrach H.,
Reinhardt R.,
Naylor S.L.,
Yang H.,
Olson M.,
Weinstock G.,
Gibbs R.A.;
"The DNA sequence, annotation and analysis of human chromosome 3.";
Nature 440:1194-1198(2006).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
INTERACTION WITH HIV-1 TAT.
DOI=10.1073/pnas.95.22.13153; PubMed=9789057 [NCBI, ExPASy, EBI, Israel, Japan]
Albini A.,
Ferrini S.,
Benelli R.,
Sforzini S.,
Giunciuglio D.,
Aluigi M.G.,
Proudfoot A.E.I.,
Alouani S.,
Wells T.N.C.,
Mariani G.,
Rabin R.L.,
Farber J.M.,
Noonan D.M.;
"HIV-1 Tat protein mimicry of chemokines.";
Proc. Natl. Acad. Sci. U.S.A. 95:13153-13158(1998).
|
[8]
|
SULFATION AT TYR-26, AND GLYCOSYLATION.
PubMed=11046064 [NCBI, ExPASy, EBI, Israel, Japan]
Preobrazhensky A.A.,
Dragan S.,
Kawano T.,
Gavrilin M.A.,
Gulina I.V.,
Chakravarty L.,
Kolattukudy P.E.;
"Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region.";
J. Immunol. 165:5295-5303(2000).
|
[9]
|
VARIANT ILE-64.
DOI=10.1126/science.277.5328.959; PubMed=9252328 [NCBI, ExPASy, EBI, Israel, Japan]
Smith M.W.,
Dean M.,
Carrington M.,
Winkler C.,
Huttley G.A.,
Lomb D.A.,
Goedert J.J.,
O'Brien T.R.,
Jacobson L.P.,
Kaslow R.,
Buchbinder S.,
Vittinghoff E.,
Vlahov D.,
Hoots K.,
Hilgartner M.W.,
O'Brien S.J.;
"Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression.";
Science 277:959-965(1997).
|
[10]
|
VARIANT ILE-64.
DOI=10.1038/nm0798-786; PubMed=9662369 [NCBI, ExPASy, EBI, Israel, Japan]
Mummidi S.,
Ahuja S.S.,
Gonzalez E.,
Anderson S.A.,
Santiago E.N.,
Stephan K.T.,
Craig F.E.,
O'Connell P.,
Tryon V.,
Clark R.A.,
Dolan M.J.,
Ahuja S.K.;
"Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.";
Nat. Med. 4:786-793(1998).
|
|